Catalan
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

anticancer/càncer de mama

L'enllaç es desa al porta-retalls
Pàgina 1 des de 242 resultats

Treatment of breast cancer with a PARP inhibitor alone or in combination with anti-tumor agents

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
BACKGROUND Cancer is a group of diseases characterized by aberrant control of cell growth. The annual incidence of cancer is estimated to be in excess of 1.3 million in the United States alone. While surgery, radiation, chemotherapy, and hormones are used to treat cancer, it remains the second

Compositions and methods for monitoring breast cancer treatment

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
BACKGROUND OF THE INVENTION Glutamine supplementation has been shown to prevent induction of mammary (breast) cancer in rats by the carcinogen 7,12-dimenthyl-benz[a]anthracene (DMBA) (Feng, Z., et al., Surgical Forum 47:524 526 (1996)). It has also been shown to enhance the effectiveness of

Compositions and methods for monitoring breast cancer treatment

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
BACKGROUND OF THE INVENTION Glutamine supplementation has been shown to prevent induction of mammary (breast) cancer in rats by the carcinogen 7,12-dimenthyl-benz[a]anthracene (DMBA) (Feng, Z., et al., Surgical Forum 47:524-526 (1996)). It has also been shown to enhance the effectiveness of

Compositions and methods for monitoring breast cancer treatment

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
BACKGROUND OF THE INVENTION Glutamine supplementation has been shown to prevent induction of mammary (breast) cancer in rats by the carcinogen 7,12-dimenthyl-benz[a]anthracene (DMBA) (Feng, Z., et al., Surgical Forum 47:524-526 (1996)). It has also been shown to enhance the effectiveness of

Markers for identifying breast cancer treatment modalities

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
BACKGROUND OF THE INVENTION Breast cancer is the most frequently diagnosed cancer and the second most common cause of cancer death in women. While endocrine therapies have proven to be initially effective, almost half of breast cancer patients eventually present recurrent tumors that are resistant

Tissue specific adenovirus vectors for breast cancer treatment

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
Tissue specific adenovirus vectors target breast cancer cells with genes that encode products that kill the cells. Despite important advances in early detection and treatment, breast cancer remains a major cause of death, with more than 40,000 deaths expected in the U.S. alone in 1996. Even with

Predicting breast cancer treatment outcome

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
FIELD OF THE INVENTION The invention relates to the identification and use of gene expression profiles, or patterns, with clinical relevance to the treatment of breast cancer using tamoxifen (nolvadex) and other "antiestrogen" agents against breast cancer, including other "selective estrogen

Methods for breast cancer treatment

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
FIELD OF THE INVENTION Disclosed herein are methods for treating breast cancer comprising predicting or assessing the efficacy of a therapeutic regimen for breast cancer and administering an effective amount of a therapeutic agent to treat breast cancer in subjects. Specifically, disclosed are

Methods of breast cancer treatment

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
FIELD OF THE INVENTION The present invention relates generally to the field of adjuvant methods and devices for breast cancer treatment. Specifically, brachytherapy methods to treat a tumor, preferably a breast tumor, are described. BACKGROUND OF THE INVENTION One method of treating breast cancer is

Method for determining breast cancer treatment

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
FIELD OF THE INVENTION The present invention relates to a method for determining a treatment procedure for breast cancer, a method of predicting a clinical response to a breast cancer treatment, and a method for selecting an endocrine therapy agent in treating breast cancer. In general, methods of

Collagens as markers for breast cancer treatment

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
TECHNICAL FIELD The claimed methods relate to biomarkers of breast cancer and methods of use thereof. BACKGROUND Breast carcinomas represent a heterogeneous group of tumors at the clinical, histopathologic, and molecular levels (Cancer Genome Atlas Network, Nature 490:61-70, 2012). The diversity of

Antitumor activity of multi-kinase inhibitors in triple negative breast cancer

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
CROSS-REFERENCE TO RELATED APPLICATIONS This application is filed under the provisions of 35 U.S.C. .sctn.371 and claims the priority of International Patent Application No. PCT/EP2015/061641, filed on 27 May 2015 entitled "ANTITUMOR ACTIVITY OF MULTI-KINASE INHIBITORS IN TRIPLE NEGATIVE BREAST

Method for assessing and predicting efficacy of breast cancer treatment with a long-acting topoisomerase I inhibitor

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
FIELD OF THE INVENTION This invention relates to (among other things) the field of cancer chemotherapy. More specifically, the invention involves the treatment of an individual suffering from a cancer such as breast cancer by administering to the individual a long-acting topoisomerase I inhibitor,

Prevention of mammary carcinogenesis and breast cancer treatment

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
The present invention relates to the use of the functional ingredients inulin, oligofructose or their derivatives for the manufacture of functional food, functional feed, OTC and pharmaceutical compositions for the prevention of mammary carcinogenesis or treatment of breast cancer. The invention

Prostate and breast cancer treatment

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
BACKGROUND OF THE INVENTION The invention provides methods and compositions comprising steroids or analogs, such as analogs of androst-5-ene-3.beta.,17.beta.-diol ("AED") or 1,3,5(10)-estratriene-17.alpha.-ethynyl-3.beta.,17.beta.-diol ("EED") for use as agents to modulate the biological activity of
Uneix-te a la nostra
pàgina de Facebook

La base de dades d’herbes medicinals més completa avalada per la ciència

  • Funciona en 55 idiomes
  • Cures a base d'herbes recolzades per la ciència
  • Reconeixement d’herbes per imatge
  • Mapa GPS interactiu: etiqueta les herbes a la ubicació (properament)
  • Llegiu publicacions científiques relacionades amb la vostra cerca
  • Cerqueu herbes medicinals pels seus efectes
  • Organitzeu els vostres interessos i estigueu al dia de les novetats, els assajos clínics i les patents

Escriviu un símptoma o una malaltia i llegiu sobre herbes que us poden ajudar, escriviu una herba i vegeu malalties i símptomes contra els quals s’utilitza.
* Tota la informació es basa en investigacions científiques publicades

Google Play badgeApp Store badge